Excelsior Biopharma Inc. (6496.TWO) Stock
—
Valuation
Financials & Margins
Valuation & Return Ratios
Ownership
About Excelsior Biopharma Inc.
—
Excelsior Biopharma Inc. is led by CEO Joseph Chen, employs 15 people, headquartered in Taipei, TW, publicly traded since 2014.
Excelsior Biopharma Inc. (6496.TWO) stock trades at $23.35 with a market capitalization of $1.11B. The stock is valued at a negative price-to-earnings (P/E) ratio of -5.36, reflecting a net loss over the last twelve months, price-to-book of 1.61, price-to-sales of 1.18. Over the past 52 weeks the stock has ranged between $22.50 and $30.55, and currently trades 23.6% below its 52-week high.
On profitability, Excelsior Biopharma Inc. generates a return on equity (ROE) of -26.05% (negative, reflecting a net loss), an operating margin of -26.21%, a net profit margin of -22.05%.
Official website: www.excelsiorgroup.com.tw
Excelsior Biopharma Inc. (6496.TWO) — frequently asked questions
What is Excelsior Biopharma Inc. (6496.TWO) stock price today?
Excelsior Biopharma Inc. (6496.TWO) is currently trading at $23.35, down 1.68% today.
What is 6496.TWO P/E ratio?
Excelsior Biopharma Inc.'s P/E ratio is -5.36. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 6496.TWO return on equity (ROE)?
Excelsior Biopharma Inc.'s return on equity (ROE) is -26.05%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Excelsior Biopharma Inc.'s market cap?
Excelsior Biopharma Inc. has a market capitalization of $1.11B.
Does 6496.TWO pay a dividend?
Excelsior Biopharma Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 6496.TWO carry?
Excelsior Biopharma Inc. has a debt-to-equity ratio of 0.76. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 6496.TWO's profit margin?
Excelsior Biopharma Inc. reports a net profit margin of -22.05% — the share of revenue left after every cost, including tax and interest.
What sector is 6496.TWO in?
Excelsior Biopharma Inc. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 6496.TWO listed on?
Excelsior Biopharma Inc. trades on TWO under the ticker 6496.TWO.
What is 6496.TWO's 52-week range?
Over the last year Excelsior Biopharma Inc. has traded between $22.50 and $30.55.
Related — Stocks
Popular Stocks
Screens 6496.TWO currently matches
On the figures above, Excelsior Biopharma Inc. passes the filters for 4 of our ready-made screens, among them Small Cap Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.